'Heads held high': An exploratory study of legal highs in pre-legislation Ireland

Journal of Ethnicity in Substance Abuse

Volumn 10, Issue 3, 2011, Pages 256-272

  Van Hout, Marie Claire ^a   Brennan, Rebekah ^b  

^a South East Technological University   (Ireland)

^b Addiction Training Institute   (Ireland)

Author keywords

designer drugs; headshops; licit psychotropic substances; mephedrone; party pills; synthetic cannabinoids

Indexed keywords

1 BENZYLPIPERAZINE DERIVATIVE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4' METHYLMETHCATHINONE; AMPHETAMINE; COCAINE DERIVATIVE; ILLICIT DRUG; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG CHOICE; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG LEGISLATION; DRUG MARKETING; DRUG QUALITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG UTILIZATION; FEMALE; HUMAN; IRELAND; LEGAL ASPECT; MALE; MEDICAL DECISION MAKING; PRESCRIPTION; PRIORITY JOURNAL; SEMI STRUCTURED INTERVIEW;

ADOLESCENT; ADULT; DATA COLLECTION; DECISION MAKING; DESIGNER DRUGS; FEMALE; HUMANS; INTERNET; IRELAND; LEGISLATION, DRUG; MALE; METHAMPHETAMINE; PSYCHOTROPIC DRUGS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 80052438852     PISSN: 15332640     EISSN: 15332659     Source Type: Journal    
DOI: 10.1080/15332640.2011.600210     Document Type: Article

References (31)

1. Archer, R. P. (2009). Fluoromethcathinone: A new substance of abuse. Forensic Science International, 185, 10-20.
2. Best, D., Strang, J., & Beswick, T. (2001). Assessment of a concentrated, high-profile police operation: No discernible impact on drug availability, price or purity. British Journal of Criminology, 41, 738-745.
3. Ceyhan, A. (2008). Technologization of security: Management of uncertainty and risk in the age of biometrics. Surveillance and Society, 5, 102-123.
4. Davies, S., Button, J., Archer, R., Ransay, J., & Holt, D. (2010). Methcathinone derivatives: Findings from test purchases of capsules and powders from the Internet. Analytical Unit and 2TICTAC Communications Ltd, London, United Kingdom: St. George's University of London and Surrey, Kingston University.
5. European Monitoring Centre for Drugs, & Drug Addiction. (2007). Risk assessment report of a new psychoactive substance: 1-Benzylpiperazine (BZP) (In accordance with Article 6 of Council Decision 2005=387=JHA on information exchange, risk assessment and control of new psychoactive substances). Lisbon: EMCDDA.
6. European Monitoring Centre for Drugs, and Drug Addiction. (2008). Council decision: 'Appropriate controls' for BZP-new drug BZP to be placed under control across the EU (News Release No 2=2008). Lisbon: EMCDDA.
7. Hammersley, R. (2010). Dangers of banning spice and the synthetic cannabinoid agonists. Addiction, 105, 373.
8. Hand, T., & Rishiraj, A. (2009). Seizures of drugs in England and Wales, 2008=09. Home Office Statistical Bulletin 16=09. London, England: Home Office.
9. Hillebrand, J., Olszewski, D., & Sedefov, R. (2010). Legal highs on the internet. Substance Use and Misuse, 45, 330-340.
10. LGC Standards. (2010). Reference Standards for 'legal highs'. Trends in Analytical Chemistry, 29(5), 3.
11. Long, J. (2010, January). Headshop drugs across Europe: Data from the EMCDDA. Paper presented at the National Regional Drugs Task Force "Legal Highs" Conference, Mullingar, Ireland.
12. Measham, F., & Moore, K. (2009). Repertoires of distinction: Exploring patterns of weekend polydrug use within local leisure scenes across the English night time economy. Criminology and Criminal Justice, 9, 437-464.
13. Measham, F., Moore, K., Newcombe, R., & Welch, Z. (2010). Tweaking, bombing, dabbing and stockpiling: The emergence of mephedrone and the perversity of prohibition. Drugs and Alcohol Today, 10(1), 14-21.
14. Menghrajani, P., Klaue, K., Dubois-Arber, F., & Michaud, P. A. (2005). Swiss adolescents' and adults' perceptions of cannabis use: A qualitative study. Health Education Research, 20, 476-484
15. Mixmag. (2010). The Mixmag Drug Survey. February, 44-53. Mephedrone: Meet the UK's Favourite New Drug. Retrieved from www.mixmag.net
16. Moore, K. (2004). A commitment to clubbing. Peace Review: A Journal of Social Justice, 16, 459-466.
17. Morris, K. (2010). UK places generic ban on mephedrone drug family. The Lancet, 17, 1333-1334.
18. Newcombe, R. (1999). Psychonautics: A model and method for exploring the subjective effects of psychoactive drugs. Paper presented at Club Health 2000, First International Conference on Nightlife and Substance Use, Amsterdam, Netherlands. Retrieved from www.drugtext.org/library/articles/newcombe02.htm
19. Newcombe, R. (2008). Ketamine case study: The phenomenology of a ketamine experience. Addiction Research & Theory, 16, 209-215.
20. Newcombe, R. (2010). Mephedrone: The use of mephedrone (m-cat, meow) in Middlesbrough. Manchester: Lifeline Publications and Research.
21. Nicholson, T. C. (2006). Prevalence of use, epidemiology and toxicity of 'herbal party pills' among those presenting to the emergency department. Emergency Medicine Australasia, 18, 180-184.
22. O'Neill, S. (2009). Cocaine being cut down to 5 per cent purity as seizures rise. Retrieved from www.timesonline.co.uk/tol/news/uk/crime/ article6562579.ece
23. Ogilvie, D., Gruer, L., & Haw, S. (2005). Young people's access to tobacco, alcohol, and other drugs. British Medical Journal, 331, 393-396.
24. Pillay, D., & Kelly, B. (2010). Recreational drugs and health information provided in head shops. The Psychiatrist, 34, 100-102.
25. Schmidt, M. (2009 September). Legal highs in the UK: Overview and the results of a user survey. Paper presented at the Psychonaut Conference, Ancona, Italy.
26. Sheridan, J., & Butler, R. (2010). "They're legal so they're safe, right?" What did the legal status of BZP-party pills mean to young people in New Zealand? International Journal of Drug Policy, 21, 77-81.
27. Thomas, D. (2003). A general inductive approach for qualitative analysis. Auckland: The University of Auckland.
28. Van Hout, M. C., & Brennan, R. (2011). Curiousity killed M-Cat: A post legislative study on mephedrone use in Ireland. Drugs: Education, Prevention, and Policy, forthcoming.
29. Vince, G. (2006). Legally high. New Scientist, 191, 40-45.
30. Wilkins, C., & Sweetsur, P. (2010). Differences in harm from legal BZP=TFMPP party pills between North Island and South Island users in New Zealand: A case of effective industry self-regulation? International Journal of Drug Policy, 21, 86-90.
31. Zemke, R., & Kramlinger, T. (1995). Figuring things out. Reading, MA: Addison Wesley.